Brian Slomovitz - Mount Sinai Medical Center;Florida International University

基本信息

Career Trajectory

Bio

A specialist in clinical trial development, robotic surgery, sentinel lymph node evaluation, and immunotherapy, Dr. Brian Slomovitz is Director of Gynecologic Oncology and Co-Chair of the Cancer Research Committee at Mount Sinai Medical Center. He is also a Professor of Obstetrics and Gynecology at Florida International University.

Dr. Slomovitz is a member of the Board of Directors at the GOG Foundation and the Uterine Cancer Lead for GOG Partners. He is also the national or global principal investigator on a number of GOG Partners, NCI, and Alliance Foundation clinical trials. He authored more than 100 peer-reviewed articles and lectured extensively. In addition, Dr. Slomovitz has been recognized as a Top Doctor by Castle Connolly Doctor for the past several years.

Research Interests

Papers共 349 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Relacorilant and Nab-Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (ROSELLA): an Open-Label, Randomised, Controlled, Phase 3 Trial

Alexander B Olawaiye,Laurence Gladieff,David M O'Malley,Jae-Weon Kim, Gabriel Garbaos,Vanda Salutari,Lucy Gilbert,Linda Mileshkin, Alix Devaux,Elizabeth Hopp,Yong Jae Lee,Ana Oaknin, Mariana Scaranti,Byoung-Gie Kim,Nicoletta Colombo, Michael E McCollum,Connie Diakos, Andrew Clamp, Aliza L Leiser, Boglárka Balázs, Bradley J Monk,Giuseppa Scandurra, Emily McClung, Emilie Kaczmarek,Brian Slomovitz, Helena De La Cueva, Aknar Freire de Carvalho Calabrich,Chiara Cassani,Benoit You,Toon Van Gorp, Cristina Churruca,Giuseppe Caruso,Shibani Nicum, Andrea Bagaméri,Grazia Artioli, Lubomir Bodnar,Sokbom Kang,Ignace Vergote, Amanda Kesner-Hays, Hristina I Pashova, Sachin G Pai,Iulia Cristina Tudor, Adrian M Jubb,Domenica Lorusso

Lancet (London, England) (2025)

Cited0Views0WOSBibtex

Improving Diverse Patient Enrollment in Clinical Trials, Focusing on Hispanic and Asian Populations: Recommendations from an Interdisciplinary Expert Panel

Bhavana Pothuri,Premal Thaker, Adrienne Moore, Rosa Espinosa, Kara Medina,Deborah Collyar,Kathleen Lutz,Mihaela C Munteanu,Brian Slomovitz

International journal of gynecological cancer official journal of the International Gynecological Cancer Societyno. 6 (2025): 101875-101875

Cited0Views0WOSBibtex

Racial and Ethnic Enrollment Disparities in Clinical Trials Leading to FDA Approvals for Gynecologic Malignancies

Gabriel Levin, Bradley J. Monk,Bhavana Pothuri,Robert Coleman,Thomas Herzog,Lucy Gilbert, Laurance bernard, Xing Zeng, Peter Scalia,Brian Slomovitz

American Journal of Obstetrics and Gynecology (2025)

Cited0Views0WOSBibtex

Pembrolizumab or Placebo Plus Adjuvant Chemotherapy with or Without Radiotherapy for Newly Diagnosed, High-Risk Endometrial Cancer: Results in Mismatch Repair-Deficient Tumors

JOURNAL OF CLINICAL ONCOLOGYno. 3 (2025)

Cited0Views0WOSBibtex

Approach to Radical Hysterectomy for Cervical Cancer after the Laparoscopic Approach to Cervical Cancer Trial and Associated Complications: a National Surgical Quality Improvement Program Study

Gabriel Levin,Pedro T. Ramirez,Jason D. Wright,Brian M. Slomovitz,Kacey M. Hamilton,Rebecca J. Schneyer,Moshe Barnajian,Yosef Nasseri,Matthew T. Siedhoff,Kelly N. Wright,Raanan Meyer

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGYno. 2 (2025)

Cited0Views0Bibtex

AFT-50 EndoMAP: A Phase IB/II Multi-Cohort Study of Targeted Agents for Patients with Recurrent or Persistent Endometrial Cancer

Evelyn Cantillo,Tyler Zemla,John Moroney,Edwin Alvarez,Yvonne Lin, Gillian DiLallo,Joyce Liu,Angeles Alvarez Secord,Andrew Nixon,Sumithra Mandrekar,Ursula Matulonis,David Kozono,Brian Slomovitz

GYNECOLOGIC ONCOLOGY（2024）

Cited0Views0Bibtex

State of the Art Endocrine Treatments for Patients Diagnosed with Endometrial Cancer in 2025

Fernanda B Musa,Kathleen N Moore, Vivek Podder,Brian M Slomovitz

Current opinion in obstetrics & gynecologyno. 2 (2024): 111-119

Cited0Views0WOSBibtex

LB012/#1602 ENGOT-en11/GOG-3053/KEYNOTE-B21: Phase 3 Study of Pembrolizumab or Placebo in Combination with Adjuvant Chemotherapy with or Without Radiotherapy in Patients with Newly Diagnosed, High-Risk Endometrial Cancer

Brian Slomovitz, Ivan Sinielnikov,Weiguo Lv,Fırat Ortaç,Kristina Lindemann,Floor Backes,Akira Kikuchi,Domenica Lorusso,Anna Dańska-Bidzińska,Vanessa Samouëlian,Maria-Pilar Barretina-Ginesta, Chyong-Heuy Lai,Bhavana Pothuri,Yu Zhang,Tally Levy, Jasmine Lichfield,Gina Lin,Robert Orlowski,Laurence Gladieff,Toon Van Gorp

International Journal of Gynecological Cancer (2024): A2

Cited0Views0Bibtex

Abstract A016: NXP800, a Novel, Small Molecule GCN2 Kinase Activator, Demonstrates Potent Single-Agent Activity in ARID1A and ARID1B-deficient Endometrial Cancer Xenograft Models

Ramez N. Eskander,Bradley J. Monk,Brian M. Slomovitz,Enrique Poradosu,Allison Woods,Shay Shemesh,Paul Clarke,Robert Te Poele,Marissa Powers,Paul Workman,Shannon N. Westin

Clinical Cancer Research（2024）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn